Cboe UK EUR

Colgate-Palmolive Company (CPAD.XC)

Compare
83.56 0.00 (0.00%)
At close: November 7 at 1:36 PM GMT
Loading Chart for CPAD.XC
DELL
  • Previous Close 83.56
  • Open 83.56
  • Bid 87.76 x --
  • Ask --
  • Day's Range 83.56 - 83.56
  • 52 Week Range 66.00 - 98.40
  • Volume 50
  • Avg. Volume 9
  • Market Cap (intraday) 70.728B
  • Beta (5Y Monthly) 0.41
  • PE Ratio (TTM) 25.24
  • EPS (TTM) 3.31
  • Earnings Date Jan 31, 2025
  • Forward Dividend & Yield 1.90 (2.27%)
  • Ex-Dividend Date Oct 18, 2024
  • 1y Target Est --

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

www.colgatepalmolive.com

34,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CPAD.XC

View More

Performance Overview: CPAD.XC

Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CPAD.XC
20.17%
S&P 500
23.08%

1-Year Return

CPAD.XC
29.64%
S&P 500
30.58%

3-Year Return

CPAD.XC
20.32%
S&P 500
29.41%

5-Year Return

CPAD.XC
20.32%
S&P 500
29.41%

Compare To: CPAD.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CPAD.XC

View More

Valuation Measures

Annual
As of 11/15/2024
  • Market Cap

    72.60B

  • Enterprise Value

    79.44B

  • Trailing P/E

    25.28

  • Forward P/E

    22.83

  • PEG Ratio (5yr expected)

    1.99

  • Price/Sales (ttm)

    3.61

  • Price/Book (mrq)

    165.25

  • Enterprise Value/Revenue

    4.16

  • Enterprise Value/EBITDA

    18.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.26%

  • Return on Assets (ttm)

    16.33%

  • Return on Equity (ttm)

    487.92%

  • Revenue (ttm)

    20.11B

  • Net Income Avi to Common (ttm)

    2.87B

  • Diluted EPS (ttm)

    3.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.49B

  • Total Debt/Equity (mrq)

    1,009.09%

  • Levered Free Cash Flow (ttm)

    2.98B

Research Analysis: CPAD.XC

View More

Company Insights: CPAD.XC

Research Reports: CPAD.XC

View More